The Incidence of Thyroid Cancer in 4474 Patients Treated for Hyperthyroidism or Goiter
|ClinicalTrials.gov Identifier: NCT01384786|
Recruitment Status : Completed
First Posted : June 29, 2011
Last Update Posted : June 29, 2011
Patients with hyperthyroidism and/or goiter are evaluated with blood samples and scintiscan before they are treated with radioiodine for their thyroid disease. Because the investigators do not get a histologically/final diagnosis the investigators want to make sure, that the patients treated do not have a thyroid cancer when treated.
The investigators have found that thyroid cancer is not overlooked.
|Condition or disease|
|Hyperthyreosis and Goiter Thyroid Cancer|
|Study Type :||Observational|
|Actual Enrollment :||4474 participants|
|Official Title:||The Incidence of Thyroid Cancer in 4474 Patients Treated for Hyperthyroidism or Goiter|
|Study Start Date :||October 2004|
|Study Completion Date :||July 2005|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01384786
|Study Chair:||Anders Vej-Hansen||Herlev Hospital, Copenhagen, Denmark|